Chemoinformaics analysis of Serpentine (alkaloid)
Molecular Weight | 348.402 | nRot | 1 |
Heavy Atom Molecular Weight | 328.242 | nRig | 26 |
Exact Molecular Weight | 348.147 | nRing | 5 |
Solubility: LogS | -5.14 | nHRing | 4 |
Solubility: LogP | 3.547 | No. of Aliphatic Rings | 4 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 46 | No. of Aliphatic Hetero Cycles | 4 |
No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 1 |
nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 21 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 2 | No. of Arom Atom | 13 |
No. of Oxygen atom | 3 | No. of Arom Bond | 14 |
nHA | 5 | APOL | 53.0119 |
nHD | 0 | BPOL | 27.2541 |
QED | 0.633 |
Synth | 4.055 |
Natural Product Likeliness | 1.125 |
NR-PPAR-gamma | 0.033 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.054 |
Pgp-sub | 0 |
HIA | 0.004 |
CACO-2 | -4.698 |
MDCK | 0.0000345 |
BBB | 0.875 |
PPB | 0.947464 |
VDSS | 1.107 |
FU | 0.0451493 |
CYP1A2-inh | 0.961 |
CYP1A2-sub | 0.786 |
CYP2c19-inh | 0.876 |
CYP2c19-sub | 0.214 |
CYP2c9-inh | 0.929 |
CYP2c9-sub | 0.271 |
CYP2d6-inh | 0.826 |
CYP2d6-sub | 0.435 |
CYP3a4-inh | 0.951 |
CYP3a4-sub | 0.738 |
CL | 5.661 |
T12 | 0.169 |
hERG | 0.611 |
Ames | 0.959 |
ROA | 0.19 |
SkinSen | 0.067 |
Carcinogencity | 0.974 |
EI | 0.015 |
Respiratory | 0.911 |
NR-Aromatase | 0.178 |
Antiviral | Yes |
Prediction | 0.768529 |